Free Trial

Crescita Therapeutics (CTX) Competitors

Crescita Therapeutics logo
C$0.64 +0.02 (+3.23%)
(As of 11/22/2024 05:18 PM ET)

CTX vs. VIR, ZOM, IN, META, LABS, CWEB, DB, NRTH, MRV, and WLLW

Should you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), MediPharm Labs (LABS), Charlotte's Web (CWEB), Decibel Cannabis (DB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Crescita Therapeutics vs.

Viridium Pacific Group (CVE:VIR) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Viridium Pacific Group has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -17.72%. Viridium Pacific Group's return on equity of 0.00% beat Crescita Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Viridium Pacific GroupN/A N/A N/A
Crescita Therapeutics -17.72%-15.79%-8.26%

In the previous week, Crescita Therapeutics had 1 more articles in the media than Viridium Pacific Group. MarketBeat recorded 1 mentions for Crescita Therapeutics and 0 mentions for Viridium Pacific Group. Viridium Pacific Group's average media sentiment score of 0.00 beat Crescita Therapeutics' score of -1.32 indicating that Viridium Pacific Group is being referred to more favorably in the media.

Company Overall Sentiment
Viridium Pacific Group Neutral
Crescita Therapeutics Negative

Crescita Therapeutics has higher revenue and earnings than Viridium Pacific Group. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Viridium Pacific Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viridium Pacific GroupC$1.09M34.46-C$12.64M-C$0.13-2.97
Crescita TherapeuticsC$16.84M0.74-C$2.98M-C$0.15-4.27

Crescita Therapeutics received 20 more outperform votes than Viridium Pacific Group when rated by MarketBeat users. However, 83.33% of users gave Viridium Pacific Group an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote.

CompanyUnderperformOutperform
Viridium Pacific GroupOutperform Votes
40
83.33%
Underperform Votes
8
16.67%
Crescita TherapeuticsOutperform Votes
60
67.42%
Underperform Votes
29
32.58%

Summary

Viridium Pacific Group beats Crescita Therapeutics on 8 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTX vs. The Competition

MetricCrescita TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$12.40MC$1.20BC$5.20BC$6.24B
Dividend YieldN/A3.13%5.53%5.42%
P/E Ratio-4.27110.9079.4725.74
Price / Sales0.741,759.861,246.761,452.58
Price / Cash1.2010.3340.9084.36
Price / Book0.723.067.192.75
Net Income-C$2.98MC$155.49MC$119.54MC$289.45M
7 Day PerformanceN/A-1.37%2.12%2.14%
1 Month Performance4.92%-5.16%-2.43%0.64%
1 Year Performance64.10%100.06%34.52%33.01%

Crescita Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTX
Crescita Therapeutics
N/AC$0.64
+3.2%
N/A+64.1%C$12.40MC$16.84M-4.2762Negative News
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
IN
InMed Pharmaceuticals
N/AN/AN/AN/AC$33.73MC$574,677.00-2.7712
META
Meta Growth
N/AC$0.14
flat
N/A+0.0%C$33.14MC$60.96M-0.6686,500Gap Down
LABS
MediPharm Labs
N/AC$0.07
flat
N/A+0.0%C$28.78MC$37.76M-1.75130
CWEB
Charlotte's Web
N/AC$0.18
flat
N/A-33.3%C$28.35MC$54.55M-0.45164High Trading Volume
DB
Decibel Cannabis
2.1168 of 5 stars
C$0.07
flat
C$0.28
+335.9%
-55.2%C$26.59MC$105.60M-6.5083,000News Coverage
NRTH
48North Cannabis
N/AC$0.07
-6.7%
N/A+0.0%C$15.76MC$18.90M-0.3047
MRV
Nuvo Pharmaceuticals
N/AN/AN/AN/AC$15.38MC$72.42M-19.29N/A
WLLW
Willow Biosciences
N/AC$0.08
flat
N/A+14.3%C$11.54MC$1.84M-1.3319

Related Companies and Tools


This page (TSE:CTX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners